Top 45 Biotechnology Angel Investors in Canada in May 2026

Bootstrapped Debt Financing

Investment focus

Software, Information Technology, Apps
Pre-Seed, Seed, Funding Round
United States, Canada, United Kingdom

Portfolio highlights

Kornem Energy — Kornem Energy provides energy intelligence and mobile-fuel delivery and diesel delivery on demand for the needs of today, tomorrow, and our future.We are eliminating the traditional fuel supply chain infrastructure using IOT & a compact terminal-to-car logistics aggregation, through service, automation and mobility.This enables us todeliver fuel directly to the customers who can request fuel delivery wherever they are, through our mobile app, while bridging the gap between feedstock aggregation, quality-assurance and end-user accessibility.No more expensive real estate, no more extensive supply chain. Just #FuelToYou
SymbaSync — SymbaSync™ helps organizations maximize return on employee investment by providing Human Resources Software to source, qualify, and engage employees to populate project teams. SymbaSync’s tools increase employee satisfaction improving employee ownership, engagement, and retention. SymbaSync provides a company with a complete overview of up-to-dateemployee skills, interests, and workplace preferences.
Tactii — We do rapid prototyping on machine learning and analytics for small companies. Our main focus is to bring down the budget for small companies and startups who want to explore things in Machine Learning. Affordable Machine Learning for startups and small companies. We are partnering up with various startups and small companies.

Show all investments...

Tom Williams

Investment focus

Software, Health Care, Financial Services
Seed, Series A, Series B
United States, Canada, India

Portfolio highlights

Unito — Unito is taking on a major problem that people are passionate about solving: they make it easier to collaborate across teams. They don't make users learn new tools and change the way they work. By connecting work management tools, they allow managers, cross-functional teams, departments, and entire companies to benefit from seamlesscollaboration and improved communication. The app syncs projects across a number of tools like Trello, Asana, JIRA, GitHub, Wrike, Zendesk & Hubspot. This is a hard problem of semantics, synchronization, and APIs.
North One — NorthOne is an online Business Account with built-in features to make business banking fast and easy. No overdraft fees. No minimum balance. No hidden fees.
Possible Finance — Get money in minutes, build credit history and avoid hidden fees with Possible Finance. Apply in the app with just a few taps and manage money on your terms.

Show all investments...

Originally trained as a medical doctor, Dr. Ray Muzyka cofounded BioWare, a video game development studio focusing on story and character, in the early 1990s. He practiced emergency/family medicine for two years full time, with medicine transitioning to part-time over the following decade as he focused on his role as BioWare’s CEO. BioWare wasacquired by Electronic Arts in 2007, and Dr. Muzyka took on the roles of Senior Vice President at Electronic Arts and General Manager of EA’s BioWare division, which grew over the next five years to span eight development locations worldwide with about 2000 staff (1400 full time). He retired from video games in October 2012, with his third “career chapter” at ThresholdImpact, where he focused on sustainable, profitable impact investing: mentoring and angel investing in information technology, new media, and medical innovations with social entrepreneurs. An active angel investor and entrepreneurial mentor, Dr. Muzyka is a member of the Young Presidents’ Organization, the A100, the Ashoka Support Network, and the Board of Governors of the University of Alberta (serving as Chair of the Human Resources Committee and on the Learning and Discovery Committee and as a member of the University of Alberta Advancement Council). He is Chair of the University of Alberta’s entrepreneur Venture Mentoring Service, a venture advisor at iNovia Venture Capital, and a member of the Alberta Research and Innovation Advisory Committee and the Alberta Premier’s Advisory Committee on the Economy. He also serves on a number of private company boards. He previously served on the board of the Academy of Interactive Arts and Sciences from 2001-2008 and was on the Board of Trustees of the Stollery Children’s Health Foundation from 2012-2015. He was inducted into the Academy of Interactive Arts and Sciences’ Hall of Fame in 2011 and received the International Game Developers’ Choice Awards 2013 Lifetime Achievement Award. Dr. Muzyka received the inaugural Alumni Innovation Award in 2015 from the University of Alberta. He additionally was named as the 2017 Allard Chair in Business at the MacEwan University’s School of Business and as an Honorary Paul Harris Fellow by Rotary Club International in 2016, in recognition for his philanthropic efforts. Other awards include entry into Canada’s Top 40 under 40 and Ernst and Young’s 2001 Entrepreneur of the Year (IT, Prairies).He obtained his Bachelor of Medical Science from the University of Alberta in 1990, his Doctorate of Medicine from there in 1992, and his MBA from the University of Western Ontario (Ivey School of Business) in 2001.

Investment focus

Health Care, Software, Information Technology
Seed, Pre-Seed, Funding Round
Canada, United States

Portfolio highlights

Leadoptik — Leadoptik is a California-based company is currently operating in stealth mode.
Modality.AI, Inc. — Modality.ai is an AI-powered platform that detects health conditions using conversational AI. Through dialogue and video, Modality.AI interacts conversationally with the patient to provide health assessment anywhere, anytime. Its system analyzes multimodal data which allows continuous screening and assessing of patients’ health.
Gray Oncology Solutions — Gray Oncology Solution is a healthcare enterprise software company that commercializes GrayOS, the operating system for oncology.

Show all investments...

Ajay Agrawal is the Co-Founder of Sanctuary Cognitive Systems Corporation. He previously worked at Queen's School of Business as a Assistant Professor. Ajay Agrawal attended the University of British Columbia.

Investment focus

Hardware, Software, Textiles
Seed, Pre-Seed
Canada

Portfolio highlights

ALT TEX — ALT TEX is creating sustainable textiles regenerated from post-industrial waste.
EcoPackers — Explore Chicken Road Casino in Canada! Play Chicken Road game and enjoy thrilling casino experiences with top bonuses and features.
EZee Assist — EZee Assist provides instant answers to franchisee operational questions. Continue using preferred channels of support and start receiving instant answers.

Show all investments...

Investment focus

Hardware, Software, Textiles
Seed, Pre-Seed
Canada

Portfolio highlights

ALT TEX — ALT TEX is creating sustainable textiles regenerated from post-industrial waste.
EcoPackers — Explore Chicken Road Casino in Canada! Play Chicken Road game and enjoy thrilling casino experiences with top bonuses and features.
EZee Assist — EZee Assist provides instant answers to franchisee operational questions. Continue using preferred channels of support and start receiving instant answers.

Show all investments...

Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.

Investment focus

Blockchain, Cryptocurrency, Software
Seed, Series A, Pre-Seed
United States, India, Singapore

Portfolio highlights

fomo — Fomo is a cutting-edge fintech startup revolutionizing the financial landscape through innovative technology and strategic partnerships.
Blitz Electric Mobility — Blitz provides electric vehicles and fleet management software to food and beverage delivery, courier, and logistics companies.
Blueprint Bryan Johnson — On the surface, Blueprint may seem something about health, wellness and aging. It's really a system to make tomorrow better for you, me, the planet and our shared future with AI.

Show all investments...

Noel Hall is the Director of Corporate of Wellcome Trust. He is a former Board Director, Co-founder, and President of Aspreva Pharmaceuticals Corp. He attended the University of London.

Investment focus

Biotechnology, Genetics, Life Science
Seed, Angel
Canada, United States

Portfolio highlights

Epistemic AI — At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us.
Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.

Show all investments...

Dr. Fong is a Professor Emeritus at the Faculty of Medicine, University of Calgary. He was formerly the Head of the Department of Radiology at the University of Calgary and the Calgary Health Region. Dr. Fong is active in funding and nurturing start-up companies. Over the past two decades, he funded over 50 companies in diverse technology sectors,with an emphasis in medical devices. Dr. Fong is the co-founder and board member of Calgary Scientific Inc. and is also on the board of Clarius Mobile Health, Cohesic Inc. and Innovere Medical. In addition to seed investing, Dr. Fong is active in the Calgary community sitting on six charitable boards and foundations.In 2015, Dr. Fong joined the Creative Destruction Lab (CDL) at the University of Toronto business school as a mentor. CDL helps young entrepreneurs to shape or pivot their nascent ideas. He is widely credited with launching CDL at the Haskayne School of Business at the University of Calgary, bringing together seasoned business leaders from Alberta, Canada and the US to grow budding companies. Dr. Fong is on the Strategic Advisory Board of CDL and a Fellow of CDL in Toronto, Montreal, Calgary and Vancouver. In 2017, Dr. Fong was named to the Order of Canada for his contribution to medical technology innovation and philanthropy.

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Angel, Pre-Seed
Canada, Singapore, United States

Portfolio highlights

Oncoustics AI — Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.
SunGreenH2 — SunGreenH2 creates the world's highest performance advanced materials for electrolysis i.e. green hydrogen production. Achieve high efficiency, low cost green H2 production on site for your application in the Power-to-X, Hydrogen refuelling, Energy Storage and Buildings sectors. Revolutionising zero emissions and improving profitability.
EZee Assist — EZee Assist provides instant answers to franchisee operational questions. Continue using preferred channels of support and start receiving instant answers.

Show all investments...

Naval Ravikant is an entrepreneur and investor. He is the co-founder and chairman of AngelList. He previously served as the CEO of AngelList. He attended Dartmouth College.

Investment focus

Software, FinTech, Blockchain
Seed, Series A, Funding Round
United States, India, United Kingdom

Portfolio highlights

Wanelo — Wanelo (“wah-nee-loh,” from Want, Need, Love) is a mall on your phone, curated by people. It helps you find the most amazing products in the universe. A regular mall has 150 stores, but on Wanelo you’ll find over 350,000 stores which include all the big brands you know, as well as tiny independent boutiques and sellers you’ve never heard of.Wanelo is also a way to search and follow all of your favorite stores in one place. It's used by millions of people who post tens of thousands of new products to Wanelo every day.Wanelo was launched in 2012 by Deena Varshavskaya, who was frustrated with shopping in traditional malls. Her personal style didn’t fit a simple category and she wanted to shop in more unique places. She decided to create a social network that would make it easy to discover amazing stores and products from anywhere online.Deena worked on Wanelo for more than two years using her own savings before attracting Wanelo’s first users. In 2011, she moved to San Francisco and raised funding after 40 investor rejections. Today, Wanelo is a team of 35, and millions of people are using it to find and buy products they love.
Polymarket — Bet on your beliefs
MicroFactory — General purpose robot to automate repetitive manual work

Show all investments...

Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr,Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.

Investment focus

Software, Artificial Intelligence, Health Care
Seed, Series A, Angel
United States, China, Canada

Portfolio highlights

tbh — tbh is a developer of a mobile application designed to provide anonymous feedback to friends. The company's mobile application facilitates asking or answering questions, open text fields and invite abuse when combined with anonymity, enabling users to say things without repercussions and feel better about themselves from the positive feedbackon social networks.
Bungalow — Bungalow is a residential real estate platform that provides renters with a more convenient, flexible, and communal living solution. It utilizes existing housing supply by signing long-term leases with homeowners, and offers multi-bedroom homes in some of the most desirable neighborhoods in cities throughout the United States.Bungalow offersprivate bedrooms with handpicked housemates in beautifully furnished homes across seven major cities. Each home comes furnished and includes wifi, utilities, housekeeping, and monthly community events for members.Andrew Collins and Justin McCarty founded Bungalow in 2016. Its headquarters is in San Francisco in California.
Raydiant — Raydiant empowers brick-and-mortar organizations to deliver engaging, personalized, and measurable on-screen digital experiences to delight in-store customers and engage back-of-house employees.

Show all investments...

Greg has a successful track record of bringing innovative solutions to the financial industry. In 1997 Greg co-founded 724 Solutions Inc., a wireless software infrastructure provider. He served as the company’s chief executive officer and led its IPO in 2000.In 1983 he founded Footprint Software Inc., a financial software company, which he sold toIBM in 1995. While at Footprint Software, Greg won the 1994 award for Canada’s Best Managed Private Company. In 1995 he won the award for Canada’s Top 40 Under 40 and in 2000 was named Entrepreneur of the Year.Greg holds a Bachelor of Arts in Computer Science from the University of Western Ontario and a double major, Biochemistry and Life Sciences from the University of Toronto.He sits on the boards of the Ontario Cancer Biomarker Network (OCBN); NoNo Inc., a company specializing in post stroke neuroprotection; and YYZ Pharmatech, which develops tools, targets, and biomarkers for pharmaceutical companies.

Investment focus

Internet, Software, Delivery
Seed, Series A
United States, Canada

Portfolio highlights

Nymi — Nymi provides a new paradigm for connecting people to their workplace on a platform, which streamlines work securely across different networks and environments. Passwordless, contactless, handsfree.
PasswordBox — Say goodbye to the hassle of passwords
Vantage — Vantage Analytics offers today’s leading online business managers a collection of powerful predictive analytics and data mining modules, served up in an accessible interface that makes data excitingly easy to work with.To make it easy to import and export your data, they have integrated connections into the most common online business services:shopping carts, web analytics and more. Just as importantly, they allow you to take immediate action through leading marketing automation tools and business apps.Vantage will inspire, guide, and support powerful marketing strategies. Leverage new customer insight to easily send targeted campaigns over email, Facebook, Twitter, Instagram, and Pinterest.Monitor campaign progress and optimize in real-time.They offer their platform on a software-as-a-service basis: Use and pay for only what you need, the rest will be ready when you are.

Show all investments...

Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Pre-Seed
United States, Canada, United Kingdom

Portfolio highlights

Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.

Show all investments...

Jeffrey Mallett was most recently the Chairman of SNOCAP, and has a rich history and proven experience in growing technology companies. As president and chief operating officer for Yahoo Inc. from 1995-2002, Mallett helped drive extraordinary growth and success for the company while simultaneously serving as an elected member of the Board ofDirectors. Mallett joined Yahoo in 1995, when the private company consisted of 12 employees and had no revenue. He helped the company go public in 1996, and during his seven year tenure, Mallett helped build Yahoo into one of the most recognizable entertainment and media brands in the world. By 2002, Mallett managed a global workforce of 4,000 employees in 27 countries, with $1 billion in revenue, and had overseen more than 20 acquisitions for the company. Mallett is currently an owner and executive committee member of the San Francisco Giants. Prior to his tenure at Yahoo, Mallett was vice president and general manager of the consumer products division of Novell, Inc. and a member of Novell's global marketing board, where he was involved with the merger of Novell and WordPerfect Corp. in 1994. He was a founding executive team member and vice president of Reference Software, an independent worldwide leader in consumer software language services, and led the company to a successful acquisition by WordPerfect in 1992. He also served as director of the Canadian-based telecommunications company Island Pacific Telephone, where Jeff drove the start-up's growth and development until it was acquired by telecommunications giant Cable and Wireless in 1987. Mallett lives in the San Francisco Bay Area with his wife of 19 years and their two children.

Investment focus

E-Commerce, Media and Entertainment, iOS
Funding Round, Angel, Series A
Canada, United States

Portfolio highlights

Gametime — Gametime sells last-minute tickets to the most popular events in sports, music, and theater. It makes finding the perfect live experience remarkably fast and easy. They curate an epic list of the most amazing possibilities in the city has to offer. Once the client selects their event it will examine over 10,000 potential seats and present them withthe 50 best values to select.Each curated seat option includes a panoramic high-resolution photo so their client can experience the actual view from their section. Navigate to the seat map to see price versus the location comparisons with true-to-life, full-color venue maps. Gametime delivers the tickets directly to the client's phone. Now they are offering sports, concerts, and theater events across the United States and Canada.
Ananda Devices — High throughput microfluidic devices to accelerate drug development in neuroscience.
Caravan Digital Studios — At Caravan, entrepreneurship runs deep. We are pioneers in the celebrity-founded model of company creation. We pride ourselves on diving into product categories that are often overlooked or untouched and creatively solving real consumer problems. Our team excels at leveraging proprietary data and reach to identify unique opportunities and build authentic brands with an immediate audience. Our extensive experience co-founding, operating and investing in companies allows us to serve as trusted partners to the artists we co-create with.

Show all investments...

Robert Simon is the Sr. Managing Partner, IT Venture Fund at BDC.

Investment focus

Software, Health Care, SaaS
Series A, Funding Round, Seed
Canada, United States

Portfolio highlights

Foko Retail — A cloud-based workforce management software with capabilities to manage time, attendance, scheduling, absence and employee communications globally.
Zymeworks — Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer.
Finch Legal — Finch Legal is a software development company that supports personal injury law firms. The company aims to provide practical and effective legal solutions, as suggested by its commitment to serving clients better and more efficiently.

Show all investments...

Nick is a co-founder and CEO at Aislelabs. Before Aislelabs, Nick co-founded Sysomos, a leading provider of social media analytics. Sysomos is used by enterprise users and digital marketers around the globe, including 70% of the Fortune 50 companies.Nick is also on the faculty at the University of Toronto's computer science department. Heholds several patents, and has published more than 100 research publications in the areas of big data analytics, information mining and searching. Nick serves on the editorial review boards of several international scientific journals in field of data management. Prior to joining the university, he was a member of AT&T's research staff.Nick is an active angel investor and mentor to several startups, including at the Creative Destruction Lab at the Rotman School of Business. Nick holds a PhD from the University of Toronto.

Investment focus

SaaS, Big Data, Hardware
Seed
Canada

Portfolio highlights

Nymi — Nymi provides a new paradigm for connecting people to their workplace on a platform, which streamlines work securely across different networks and environments. Passwordless, contactless, handsfree.
Granify — Granify is an e-commerce conversion and revenue optimization technology powered by machine learning that regularly brings top retailers 3%-5% uplift.

Show all investments...

Haig Farris is one of Canada's best-known venture capitalists and experts in high-technology start-ups and turn-arounds, with a varied 30+ year history of involvement, commitment, and management. He has a law degree from the University of Pennsylvania. He is co-founder and former Executive Chair of the Board of Directors of D-Wave, and he isthe President of Fractal Capital, a private venture capital company financing high technology start-ups and resource service technology companies.Previously, Dr. Farris was a co-founder and partner of the Ventures West Management group of venture capital funds (1972-1990). In 2001, he received the British Columbia Technologies Industry Association's (BCTIA) Bill Thompson Award.He was awarded an Honorary Doctor of Laws degree from UBC in 1997 and named A Pioneer of Innovation by the Vancouver Board of Trade in 2001.

Investment focus

Biotechnology, Genetics, Life Science
Seed, Pre-Seed
Canada, United States

Portfolio highlights

Epistemic AI — At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us.
Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.

Show all investments...

Jon Oringer is the founder and chairman of Shutterstock.

Investment focus

Software, Information Technology, Health Care
Seed, Pre-Seed, Series A
United States, United Kingdom, France

Portfolio highlights

ToolBelt — The only platform built specifically for licensed pros in residential construction looking for work or finding labor.
Scaler — Scaler empowers real estate managers to protect investments, reduce operational costs, and meet reporting obligations. Our best-in-class tech delivers faster decisions, smarter strategies, and audit-ready documentation across your entire real estate portfolio
OneImaging — OneImaging makes life-saving diagnostics affordable, accessible, and personal. We connect employers, health plans, and members to a trusted national network of imaging centers, delivering faster answers with transparent pricing and premium care across MRIs, CT scans, ultrasounds, mammograms, X-rays and more. We serve organizations looking to control medical spend and individuals who need reliable results without delays. Every scan booked through OneImaging is proof that healthcare can be simpler, cheaper, and kinder.

Show all investments...

Aravind Srinivas is a Angel investor.

Investment focus

Biotechnology
Series A
Canada

Portfolio highlights

Synex Medical — Synex Medical develops non-invasive blood testing technology. This portable device will allow users to monitor metabolite concentrations without having to penetrate skin. They use a miniaturized magnetic resonance system to detect blood metabolites. The system only consists of magnets and radio waves, meaning there are no negative health effects.

Show all investments...

Barney Pell was the co-founder, Chairman and Chief Strategy Officer of LocoMobi Inc. Barney has a long history as a leading technology innovator, product visionary, entrepreneur and angel investor based in Silicon Valley. Barney is known for being an Entrepreneur-in-Residence at Mayfield, a top Venture Capital firm, which he left to becomeFounder and CEO of Powerset, which built a natural-language based search engine that read each sentence in Wikipedia and answered user queries in plain English. Microsoft acquired Powerset in 2008 to help create its new search engine, Bing. Barney then served Microsoft as Search Strategist, Evangelist, and Chief Architect for Local Search at Bing, until leaving Microsoft in September 2011 to return to the start-up world full-time.Barney also has active investor, board member, and advisory roles with multiple start-up companies and non-profits across a variety of industries. Barney is Co-Founder, Vice Chairman and Chief Technology Officer of Moon Express, a private company building autonomous robotic lunar landers to enable exploration and commercial development of the solar system. This builds on his earlier career managing advanced software technologies at NASA. Highlights of innovations during Barney’s career at NASA include mission critical software to support planning and collaboration for the Mars Exploration Rovers mission; Clarissa, the first spoken dialog system in space; and the development of the Remote Agent, the first AI system to fly onboard and control a deep space probe. Remote Agent is widely considered one of the top achievements in the history of Artificial Intelligence and was awarded NASA’s "software of the year" award in 1999. Barney is also Associate Founder and Trustee of Singularity University (SU), a new university created to educate leaders for life in a future driven by accelerating technological change.Other recent active angel investments and advisory positions include: Getaround, Robotex, Halcyon Molecular, SpaceX, and CrowdFlower. Recent start-ups that have had successful exits include: Appjet (now Google), Aardvark (now Google), Hot Potato (now Facebook), Etacts (now SalesForce.com), Movity (now Trulia), and LinkedIn, the world’s largest professional social network which recently went public after acquiring its hundred-millionth member.Barney received his Ph.D. in Computer Science from Cambridge University, where he was a Marshall Scholar, and his B.S. degree in Symbolic Systems from Stanford University, where he graduated Phi Beta Kappa and was a National Merit Scholar.Barney is a frequent speaker at conferences and universities. These include keynote talks at the International Joint Conference on Artificial Intelligence, the Association for Computational Linguistics, Search Marketing Expos, International Semantic Web Conference, World Wide Web Conference, the Informational Retrieval Conference, and panels at SXSW Interactive. Barney has also spoken at the NPA and IPI conferences and has been featured in all major Parking industry magazines.

Investment focus

Mobile, Software, Information Technology
Seed, Series A, Pre-Seed
United States, Canada

Portfolio highlights

Workwolf — Workwolf is a Toronto-based start-up with a management team who has led 7 start-ups, had 2 successful exits, and has taken a company public with a $1.8B IPO. Workwolf CEO Erik Simins is an SME in HR who previously founded MAGNUS HRS, a staffing company now servicing over 150 enterprise customers. The technology at Workwolf solves two of the biggestpain points in employment: applicant filtration and verification, and does so by empowering users to identify better candidates faster. Winner of global awards in both 2020 and 2021 for innovation and market potential, Workwolf is ramping up for its multi-national roll-out with ManpowerGroup in September that will coincide with a $4.5M Seed financing round.
Ada — Ada is a computer software company that features a chatbot-based platform that helps enterprise businesses to automate customer experience. Its platform operates through both web and mobile machine learning engine that reduces support volume and empowers customers to find answers on their own.The company was founded in 2016 and headquartered inToronto in Canada.
Careteam Technologies — Innovating solution that enables virtual care coordination and collaboration within and between health organizations, including the patient, family and community. We enable patient medical home care continuity, care transfers, care pathways, patient engagement, and quality improvement methods using data in health.

Show all investments...

Lawrence Bloch, M.D., J.D. is the former President of Infinity. He joined the company as chief financial officer and chief business officer in 2012 and has played a key role in developing and executing the company’s corporate and financial strateBeforeior to joining Infinity in 2012, Dr. Bloch served as chief executive officer of NeurAxon, Inc., acompany focused on developing next-generation pain therapeutics, from 2007 to 2011. Previously, he served as chief business officer and chief financial officer of NitroMed, Inc., raising $150 million in equity and $20 million in venture debt to support the commercial launch of BiDil®. From 1999 to 2004, he served as chief financial officer and vice president of business development of Applied Molecular Evolution, Inc., leading the company’s $101 million initial public offering and $420 million merger with Eli Lilly and Company.Dr. Bloch began his career as an emergency medicine resident physician at Massachusetts General Hospital and Brigham & Women’s Hospital. He holds a J.D. from Harvard Law School, an M.D. from Harvard Medical, School, and an MBA from Harvard Business School.

Investment focus

Neuroscience, Therapeutics, Biotechnology
Series B, Debt Financing
Canada

Portfolio highlights

NeurAxon — NeurAxon, Inc. discovers and develops pain therapeutics targeting neuronal nitric oxide synthase. It has oral products in pipeline addressing acute migraine, neuropathic pain chronic daily headache, inflammatory pain, migraine prophylaxis, and severe pain. The company was founded in 2004 and is headquartered in Toronto, Canada.

Show all investments...

Shaz Khan is the Chief Strategy Officer/Co-Founder at Vroozi

Investment focus

Hardware, Biometrics, Health Care
Debt Financing
Canada

Portfolio highlights

OMsignal — Discover our range of Hexoskin and Astroskin Smart Garments for health and fitness tracking. Find the perfect Shirts and Kits for your needs today!

Show all investments...

Paul Stamets, speaker, author, mycologist, medical researcher and entrepreneur, is considered an intellectual and industry leader in fungi: habitat, medicinal use, and production. His research is considered breakthrough by thought leaders for creating a paradigm shift for helping ecosystems worldwide. He has received numerous awards, including:Invention Ambassador (2014-2015) for the American Association for the Advancement of Science (AAAS), the National Mycologist Award (2014) from the North American Mycological Association (NAMA), and the Gordon & Tina Wasson Award (2015) from the Mycological Society of America (MSA). In 2020, Paul was inducted into the Explorer’s Club. He has been awarded myriad patents in the field of mycology. Paul is the founder and sole owner of Fungi Perfecti, LLC,  the maker and marketer of the category-leading myco-supplement Host Defense line.

Investment focus

Medical, mHealth, Wellness
Seed
Canada

Portfolio highlights

Quantified Citizen — Join groundbreaking studies, receive rich health insights and make an impact on global health and science. Download Quantified Citizen today!

Show all investments...

Joe Betts-Lacroix is the Founder and CEO of Retro. He previously worked at Recursion as an Advisor. Joe Betts-Lacroix attended Harvard University.

Investment focus

Life Science, Biotechnology, Pharmaceutical
Seed
United States

Portfolio highlights

VitaDAO — Join VitaDAO, a community owned collective funding early stage longevity research. We fund and commercialize longevity therapeutics.
Spring Discovery — Giving Scientists AI Superpowers

Show all investments...

Sandra MacPherson

Investment focus

Genetics, Biotechnology, Medical Device
Seed
Canada

Portfolio highlights

Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.

Show all investments...

Ran Tuttnauer

Investment focus

Health Care, Big Data, Internet
Seed, Series A
Israel, Canada, United States

Portfolio highlights

Innovopro — InnovoPro is committed to bringing unique plant-based protein ingredients to the global food market in order to create nutritious, tasty, safe, and sustainable food products. With an excellent nutritional profile, free from properties and wide usability in the food industry, InnovoPro’s chickpea protein is the best choice for the growingplant-based protein market.InnovoPro was founded on 2013 by Dr. Ascher Shmulewitz an experienced inventor and investor, and has made considerable progress in developing chickpea proteins and other chickpea ingredients.InnovoPro has been recognized as an innovator of disruptive technology in the food industry.
Solidify — The Marketplayz platform helps you find the perfect creators to promote your products. It utilizes AI-powered technology to enable advertisers and creators to connect through a one-stop, self-service marketplace.
Geneyx — Geneyx offers a superior NGS data analysis and interpretation platform, Harnessing genetic data to guide digital insights for rare and germline disorders.

Show all investments...

blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.

Investment focus

Health Care, Biotechnology, Robotics
Seed, Series A, Pre-Seed
United States, Canada, India

Portfolio highlights

Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement

Show all investments...

Martin LeBlanc currently works as the Chief Executive Officer for CellCarta. He previously worked at Caprion Biosciences Inc. as the Co-Founder, President, and CEO.

Investment focus

Medical, Health Care, Biotechnology
Seed
Canada

Portfolio highlights

Saguaro Technologies — Saguaro Technologies offers innovative cell culture products that help scientists work with in vitro models that are more predictive of results in clinical trials with humans.

Show all investments...

Jacky is dedicated to angel investment and has built up a portfolio of more than thirty startup companies in Canada and the US. His target investments are the early-stage B2B companies with disruptive technologies and business potential in enterprise software, information technologies, MedTech, and Advanced Manufacturing.Jacky has acquiredconcrete business experiences as a successful founder in the startup ecosystem and an executive of Fortune 500 companies over two decades. His remarkable accomplishments range from building startups from scratch to leading a billion-dollar business with the leverage of 14,000 enterprise channel partners. The unique journey has shaped Jacky's outstanding of investing in early startups.Jacky holds the degrees of Mater's E.E. and MBA, and he graduated from CEIBS and The Wharton Business School of the University of Pennsylvania.

Investment focus

Software, Health Care, Information Technology
Seed, Pre-Seed, Funding Round
Canada, United States, China

Portfolio highlights

Workwolf — Workwolf is a Toronto-based start-up with a management team who has led 7 start-ups, had 2 successful exits, and has taken a company public with a $1.8B IPO. Workwolf CEO Erik Simins is an SME in HR who previously founded MAGNUS HRS, a staffing company now servicing over 150 enterprise customers. The technology at Workwolf solves two of the biggestpain points in employment: applicant filtration and verification, and does so by empowering users to identify better candidates faster. Winner of global awards in both 2020 and 2021 for innovation and market potential, Workwolf is ramping up for its multi-national roll-out with ManpowerGroup in September that will coincide with a $4.5M Seed financing round.
Agile Devices — Agile Devices offer catheter-based interventional procedures helping patients during a stroke. It helps medical practitioners reduce the procedure time to respond to time bound emergencies.
Traction Technology Partners — Traction is a powerful SaaS collaboration platform for evaluating, adopting and managing new technologies across the enterprise. The platform includes Project Management and CRM tools designed specifically for enterprise teams tasked with discovering and evaluating new technologies. Traction is used by IT, Innovation and Corp Dev teams toaccelerate their digital transformation projects, and to speed up the way they find, manage, and adopt new technologies. Traction also offers On-Demand Research services delivered through its platform.

Show all investments...

Claudette is an award-winning Technology Leader with 17+ years of success leading digital transformation, optimizing infrastructure, designing new support approaches to improve service experience. She has led more than 600 IT professionals in the planning, engineering and support of workplace technologies across all BMO branches and office towers.Claudette began her IT career in healthcare at Wellesley Hospital. She later joined the Computing and Telecommunications Division at the Metropolitan Toronto Police Services. Before joining BMO, Claudette spent 4 years at Deloitte where she was a key member of the Technology Management Team.In 2008, Claudette founded Excelovate, a human services company designed to help people and enrich lives through the creation of new products and services. Her work has played a pivotal role in launching the first innovation centre in Aurora, Rap Riderz Innovation Centre.Married and a mother of two, Claudette's commitment to the community is evident in her passion for literacy and everything technological. Claudette has authored five books and in partnership with First Book Canada and other leading corporations, Claudette launched the Black Arts and Innovation Expo (BAIE) as a novel way to celebrate Black History Month. The BAIE promotes diversity and inspires excellence in Science, Technology, Engineering, Arts and Mathematics by showcasing the outstanding achievements of current innovators in the arts, entrepreneurship and technology.Claudette is a recipient of a 2014 Green4Good Visionary award and in 2015 she was hailed as a BBPA Exchange - Woman of Honor and among the Top 100 Black Women to watch in Canada.

Investment focus

Apps, Hospital, Software
Angel, Grant
Canada

Portfolio highlights

Areto Labs — Areto Labs is a human-focused cyber security company that uses AI to protect people by detecting and counteracting online abuse.
PragmaClin Research — PragmaClin Research Inc. is aiming to help patients monitor their symptoms faster with the use of our remote patient monitoring system, PRIMS (Parkinson's Remote Interactive Monitoring System).

Show all investments...

Fred has served as our Chief Executive Officer since April 2016. As CEO, he has led the transformation of IMV into a leading clinical-stage immune-oncology company with world-class collaborators and a strong scientific foundation. He has more than 21 years of experience in the biopharmaceutical industry, having served in several managementpositions encompassing business development, intellectual property, strategic planning, pre-marketing, and communication. Before joining IMV, Fred spent 14 years at Medicago serving in many roles of increasing responsibility, most recently as Vice President of Business Development and Strategic Planning. He had been an integral part of Medicago’s success, including securing more than $300M CAN in non-dilutive funding in revenues and future milestones from licensing agreements and government contracts, and the $357M CAN deal acquisition by Mitsubishi Pharma in 2013.Fred is also a Director of CQDM, a biopharmaceutical research consortium and served as second Vice-Chair of the Vaccine Industry Committee of Biotech Canada between 2012 and 2016. Prior to Medicago, Fred was Licensing Manager at the University Paris VII-Denis Diderot, one of the largest sciences and medical university in France. He owns a BSc degree in Biology and a Master’s degree in Biotechnology and Business Management from the University of Angers (France).

Investment focus

Medical, Health Care, Biotechnology
Seed
Canada

Portfolio highlights

Saguaro Technologies — Saguaro Technologies offers innovative cell culture products that help scientists work with in vitro models that are more predictive of results in clinical trials with humans.

Show all investments...

Over the course of the last decade, first as a graduate student at Harvard University in the Department of Molecular and Cell Biology with PhD advisor Professor Stuart Schreiber and then as an independent postdoctoral fellow at the Lewis-Sigler Institute at Princeton University, Dr. Ethan Perlstein developed an approach to studying old drugs anddiscovering new drugs in model organisms called evolutionary pharmacology. Ethan is an author on 19 peer-reviewed scholarly publications, including the discovery of a novel mechanism of action for the antidepressant Zoloft based on studies in yeast cells.

Investment focus

Biotechnology, Cannabis, Biopharma
Seed
United States, Canada

Portfolio highlights

Epinoma — Epinoma is a diagnostics company that focuses on the multi-omics approach to cancer monitoring. It engineers proteins that control the operating system of biology. The company was founded in 2020 and is headquartered in San Francisco, California.
BluumBio — BluumBio develops next-generation remediation technologies that clean up pollution and restore degraded ecosystems
Promakhos Therapeutics — A Boston-based biotech startup developing therapeutics.

Show all investments...

Carol Leaman is the CEO of Axonify Inc., a Waterloo-based next generation eLearning company that combines gamification with brain science to revolutionize the way companies think about and deliver training to employees.Axonify makes learning stick with personalized, bite-sized information delivered in a fun, rewarding way that drives real learningtransfer and is saving companies millions. Carol won the Fortune Brainstorm Tech Pitch Competition in July 2012 against 4 other early stage technology companies garnering Axonify worldwide recognition as an emerging leader in the eLearning space.Prior to forming Axonify, Carol was the CEO of PostRank Inc. a social media engagement platform company that she sold to Google in June 2011. Carol is a serial entrepreneur and a Chartered Accountant who has been running and advising early stage technology companies for almost 15 years.

Investment focus

Health Care, Hospital, Neuroscience
Seed, Angel, Series A
Canada

Portfolio highlights

KeyOps — A revolutionary physician engagement platform that allows doctors to quickly share their expert opinions with healthcare stakeholders such as government institutions, hospitals, universities, and life science companies.
Trusscore — Trusscore is changing residential and commercial construction with products that combine sustainable materials with nanotechnology. Our PVC-based wall and ceiling panels are easy-to-install and high-performance replacements for traditional drywall and fiber-reinforced plastic panels.
PragmaClin Research — PragmaClin Research Inc. is aiming to help patients monitor their symptoms faster with the use of our remote patient monitoring system, PRIMS (Parkinson's Remote Interactive Monitoring System).

Show all investments...

Jed McCaleb is based out of San Francisco, California and is the Founder of Vast. Jed previously worked at Ripple as a Co-Founder.

Investment focus

Internet, Payments, SaaS
Seed, Series A, Initial Coin Offering
United States, Canada

Portfolio highlights

Bold Financial Technologies — Bold Financial Technologies is a payment and compliance operations for on-demand service operators. It's payouts stack to pay new publishers globally offers a REST API integration, from background checks to driving record screening and local currency payouts; and provides Bold Payouts platform, a solution for marketplaces to leverage a singleintegration that offers a back-office payout infrastructure.Bold Financial Technologies streamlines the process of mass payouts while exponentially growing the international reach of its clients. It also provides a complete administrative platform, including Tax tracking and reporting, recipient onboarding, a client administrative portal, a recipient portal, and an API.It was founded in 2014 and is headquartered in San Francisco, California.
Stream Token — Stream is a new decentralized blockchain-based token that allows livestreamers to easily and anonymously accept payments from their audience members anywhere in the world, with extremely low transaction fees and no platform lock-in.
Propellon Therapeutics — Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein, essential for assembly of methyltransferase complexes and proper histone modification. The overexpression of WDR5 and resulting deregulation of epigenetic mechanisms are implicated in various cancers and correlated with poor patient survival.Established by FACIT, Propellon’s WDR5 inhibitor platform arises from discoveries, research and innovations originating from OICR.

Show all investments...

Lee Lau is a Partner and Co-Founder of Alignvest Management Corporation. Mr. Lau co-founded ATI Technologies in 1985 and built the company into one of the world’s largest supplier of graphic chips and add-in boards to the personal computer industry. In addition to managing the company, Mr. Lau was ATI’s largest shareholder, first employee andresponsible for innovation and development of all products. Mr. Lau helped build ATI into a TSX and NASDAQ listed global market leader, with annual sales in excess of $2.2 billion and over 3,000 employees. ATI was sold in 2006 to Advanced Micro Devices for cash and stock consideration of $5.3 billion. Since then, Mr. Lau has managed his family office investing in a variety of alternative asset products. Prior to founding ATI, Mr. Lau held various design engineering positions with Mitel, Motorola and Plessey.Mr. Lau holds a Masters in Engineering and a BASc from the University of Toronto.

Investment focus

Software, Wearables, Internet of Things
Seed, Convertible Note
Canada

Portfolio highlights

Nymi — Nymi provides a new paradigm for connecting people to their workplace on a platform, which streamlines work securely across different networks and environments. Passwordless, contactless, handsfree.
Lumotune — We are creating a platform to transform the world’s glass into digital displays.
Springdel — Move beyond cloud and legacy MDM with an enterprise-grade EdgeOps platform purpose-built for the interactive Edge of Things.

Show all investments...

Lip-Bu Tan is based out of Santa Clara, California, and is the Chief Executive Officer of Intel. Lip-Bu previously worked at Cadence Design Systems as a President and Chief Executive Officer. Lip-Bu Tan attended Nanyang Technological University.

Investment focus

Software, Artificial Intelligence, Semiconductor
Seed, Series A, Series B
United States, Israel, India

Portfolio highlights

Sycamore — Sycamore provides an operating system for enterprises to build, deploy, and manage autonomous AI agents. The platform enables organizations to generate production-ready applications, integrations, and agents from natural language input while maintaining oversight and security. Agents operate under a progressive trust framework, allowing them togain autonomy based on performance, with all actions being auditable and governed.The system captures organizational knowledge and supports continuous learning, enabling multi-agent coordination and adaptation over time. It integrates security, compliance, and governance features to ensure controlled and traceable operations. Sycamore also facilitates experimentation with agent behavior, safety, and meta-learning to improve enterprise workflows through automated intelligence.
Clockwork Systems — 100% Software based solution to speed AI Jobs, eliminate Link/NIC failures and boost GPU utilization. Clockwork.io is built on breakthrough technology developed at Stanford University.
SignalRank — SignalRank Corporation is a FinTech company in the Venture space. It focuses on the seed stage asset class and uses data analytics to allocate capital to the best seed fund managers for their top performing companies. GPRank and CompanyRank are two proprietary algorithms it leverages to automate capital allocation. The company invests from balancesheet. Its customers are seed stage investors with outstanding companies in their portfolio.

Show all investments...

Nilesh is co-founder and CTO of Aislelabs and he leads the product development and engineering. Before Aislelabs, Nilesh co-founded Sysomos in 2007. Sysomos went on to become the most advanced social media analytics platform of its kind, serving 70% of the Fortune 50 enterprises, and was later acquired in 2010. Nilesh is also an angel investorand advisor to a number of startups and incubators including Extreme Startups, MaRS Jolt, Bionym, and Granify. Nilesh has significant experience in building robust and scalable software systems, data management platforms and big data analytics solutions. Nilesh's work has appeared in leading research forums worldwide.Nilesh holds a PhD, Computer Science from the University of Toronto, and a B.Tech. Computer Science and Engineering from the Indian Institute of Technology (IIT) Bombay.

Investment focus

SaaS, Big Data, Hardware
Seed
Canada

Portfolio highlights

Nymi — Nymi provides a new paradigm for connecting people to their workplace on a platform, which streamlines work securely across different networks and environments. Passwordless, contactless, handsfree.
Granify — Granify is an e-commerce conversion and revenue optimization technology powered by machine learning that regularly brings top retailers 3%-5% uplift.

Show all investments...

Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.

Investment focus

Software, E-Commerce, Health Care
Seed, Series A, Angel
United States, Canada, India

Portfolio highlights

SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
Character.ai — Chat with millions of AI Characters on the #1 AI chat app. Where will your next adventure take you?
Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.

Show all investments...

Lance Tracey - Founding Partner @ Full Stack

Investment focus

Internet, Software, Communities
Seed, Angel, Pre-Seed
Canada, United States

Portfolio highlights

Taloflow — Taloflow analyzes 4,000+ vendor data points to provide you with the best possible recommendation for cloud object storage. Complete a 5-minute use case questionnaire to get started.
SceneBox — SceneBox helps computer vision engineers sift through their large datasets to uncover the failure states and interesting data they need to train machine learning models faster.
Quantified Citizen — Join groundbreaking studies, receive rich health insights and make an impact on global health and science. Download Quantified Citizen today!

Show all investments...

Prior to Maginatics, Amarjit co-founded and helped lead three companies that built lasting technologies. He was co-founder and VP of business development and sales at SiByte (acquired by Broadcom), co-founder and EVP of business development and sales at PA Semi (acquired by Apple), and co-founder and CEO of Agnilux (acquired by Google).Earlierin his career, Amarjit was director of sales for strategic accounts in Digital Equipment Corporation’s semiconductor group. After that business unit was purchased by Intel, he served in a similar capacity for Intel. Amarjit also worked for many years at Texas Instruments in its technical sales organization.Amarjit received a BS degree in Electrical Engineering from San Jose State University.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Convertible Note
United States, Canada

Portfolio highlights

Asato — Asato is a Business Observability solution designed to help CIOs oversee all their distributed assets.*
Virtue AI — Virtue AI operates as an AI security and compliance platform for applications.
Gimlet Labs — Gimlet Labs is an applied research lab focused on building high performance AI systems.

Show all investments...

Daniel Debow is the Chair of the Board of Build Canada. He attended the Stanford Law School.Daniel is the Vice President of Product (Demand) at Shopify. He previously worked as an SVP at Salesforce.com, where he drives marketing for Salesforce Work.com, a sales performance management solution that helps Facebook, LinkedIn, Spotify, and otherinnovative companies align, motivate, and drive the performance of their sales teams. Prior to joining Salesforce, Daniel was co-founder and co-CEO of Rypple, a social performance management platform acquired by Salesforce in 2012. Prior to Rypple, Daniel was on the founding team of Workbrain, which provided workforce management solutions to Wal-Mart, Citibank, and other large enterprises. Workbrain grew to $100 million in annual revenues before being acquired by Infor in 2007.A sought after speaker on how social media is changing the workplace, Daniel is a contributor to Fortune.com and the Huffington Post. He’s been widely quoted in Wired, the Financial Times, the Economist and Bloomberg Businessweek. Daniel holds a JD/MBA from the University of Toronto and an LLM in Law, Science and Technology from Stanford University.

Investment focus

Software, SaaS, FinTech
Seed, Series A, Pre-Seed
Canada, United States

Portfolio highlights

Shakepay — Shakepay allows Canadians to buy/sell bitcoin and pay their friends. We're on a mission to create open access to building wealth.
Spatial — Experience virtual NFT art exhibitions, meetups, and live events together with lifelike avatars. Customize beautiful 3D spaces. Join now from Web, Mobile, & VR.
Haloo — Navigating the trademark search and registration process can be daunting and onerous for business owners and entrepreneurs. Heirlume is the first self-serve online trademark search and registration platform that integrates sophisticated legal thinking with technology. We make the complex trademark search and registration process fast, accurate,trusted and affordable for entrepreneurs and enterprise/e-com partners. Our search tool instantly runs the country-specific legal tests (i.e., “likelihood of confusion”) and performs lawyer analysis. Intelligent search algorithms provide an at-a-glance opinion of registerability (conflicts, descriptiveness, obscenity), displayed in simple visuals. Distilling the multiple data sets involved with drafting a trademark application requires time-consuming legal analysis. Our machine learning auto-suggest trademark application builder performs the lawyer work and removes room for error. While our first go to market strategy will target SME individual users, we see huge potential in expanding our market reach through key B2B partnerships as an upsell/add-on to a domain purchase (GoDaddy), or store set-up (Shopify or Amazon). Ultimately, we believe we can make trademark registration quick, easy and affordable, similar to the experience of registering a domain.

Show all investments...

Jon Oringer is the founder and chairman of Shutterstock.

Investment focus

Software, Information Technology, E-Commerce
Seed, Pre-Seed, Series A
United States, United Kingdom, France

Portfolio highlights

SLUSHY — SLUSHY is a secure mobile web based platform for content creators to find, grow, & monetize their audiences. A creator first, tech-driven tool, designed with key discoverability features and audience insights. In a market where existing solutions (OnlyFans, Patreon) fall short of their creators' demands, SLUSHY provides an alternativesolution for professional content creators that prioritizes their monetization, support and management needs. SLUSHY incorporates a powerful legal framework, with robust compliance tools including simplified consent, ID verification, and content moderation. The new home of unrestricted content, SLUSHY is here.
Unsloth AI — Unsloth is an open-source, no-code web UI for training, running and exporting open models in one unified local interface.
OneImaging — OneImaging makes life-saving diagnostics affordable, accessible, and personal. We connect employers, health plans, and members to a trusted national network of imaging centers, delivering faster answers with transparent pricing and premium care across MRIs, CT scans, ultrasounds, mammograms, X-rays and more. We serve organizations looking to control medical spend and individuals who need reliable results without delays. Every scan booked through OneImaging is proof that healthcare can be simpler, cheaper, and kinder.

Show all investments...

Rami Essaid is the Co-Founder and Chief Executive Officer of Finmark, a Venture Partner at IDEA Fund Partners, and an Extended Team Member of Ubiquity Ventures. He was the Co-Founder and Chairman of Distil. Rami helps enterprises embrace the cloud to improve their scalability and reliability while maintaining a high level of security.He attendedNorth Carolina State University where he majored in computer engineering.

Investment focus

SaaS, Data Mining, Life Science
Seed
Canada, United States

Portfolio highlights

Kontigo — We help underbanked gig workers in Latam build credit and access group financing where small groups of family or friends lend and save money together. Users can validate their income from multiple sources such as gig apps, catalog sales, and open finance (Uber, Rappi, Didi, Indriver, Avon, and all major banks). After verifying the income wedirectly offer them group savings and group loans, without leaving WhatsApp, their primary messaging app.
Prospectify — #1 trusted site to buy youtube subscribers India. Offer high quality, safe and legit buy youtube subscribers cheap prices and order starts in 24-48 Hrs
Propellon Therapeutics — Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein, essential for assembly of methyltransferase complexes and proper histone modification. The overexpression of WDR5 and resulting deregulation of epigenetic mechanisms are implicated in various cancers and correlated with poor patient survival.Established by FACIT, Propellon’s WDR5 inhibitor platform arises from discoveries, research and innovations originating from OICR.

Show all investments...

Dan Schultz

Investment focus

SaaS, Data Mining, Life Science
Seed
Canada, United States

Portfolio highlights

Prospectify — #1 trusted site to buy youtube subscribers India. Offer high quality, safe and legit buy youtube subscribers cheap prices and order starts in 24-48 Hrs
Propellon Therapeutics — Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein, essential for assembly of methyltransferase complexes and proper histone modification. The overexpression of WDR5 and resulting deregulation of epigenetic mechanisms are implicated in various cancers and correlated with poor patient survival.Established by FACIT, Propellon’s WDR5 inhibitor platform arises from discoveries, research and innovations originating from OICR.

Show all investments...

Collin Terpstra is an allergy specialist.

Investment focus

Medical, Health Care, Biotechnology
Series A
Canada

Portfolio highlights

Kenota Health — Kenota Health develops next-generation rapid point-of-care system intended to be used for allergy testing in humans. Kenota's diagnostic tools are safe, simple, and offer a cheaper alternative to allergy testing using a thorough non-invasive technology, enabling physicians to improve patient outcomes.

Show all investments...